{
    "id": 26563,
    "fullName": "DDR1 del",
    "impact": "deletion",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "DDR1 del indicates a deletion of the DDR1 gene.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 780,
        "geneSymbol": "DDR1",
        "terms": [
            "DDR1",
            "CAK",
            "CD167",
            "DDR",
            "EDDR1",
            "HGK2",
            "MCK10",
            "NEP",
            "NTRK4",
            "PTK3",
            "PTK3A",
            "RTK6",
            "TRKE"
        ]
    },
    "variant": "del",
    "createDate": "05/12/2017",
    "updateDate": "05/15/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 10880,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, 7RH treatment had no effect on tumor growth in KRAS G12V-driven animal models of lung cancer with DDR1 knockout background (PMID: 26855149).",
            "molecularProfile": {
                "id": 27817,
                "profileName": "DDR1 del KRAS G12V"
            },
            "therapy": {
                "id": 5669,
                "therapyName": "7RH",
                "synonyms": null
            },
            "indication": {
                "id": 1324,
                "name": "lung cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 8887,
                    "pubMedId": 26855149,
                    "title": "Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26855149"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27816,
            "profileName": "DDR1 del",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 27817,
            "profileName": "DDR1 del KRAS G12V",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}